Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1235.00
-10.50 (-0.84%)
< Home < Back

Dr. Reddys Laboratories informs about press releases

Date: 09-09-2020

Dr. Reddys Laboratories has informed that it has enclosed two Press Releases on 9th September 2020 titled ‘Dr. Reddy's Laboratories announces the launch of Redyx in India’ and ‘Dr. Reddy's Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market’.

The above information is a part of company’s filings submitted to BSE.